Please assess the completion status of the following clinical trial:

Trial Title: A European Study on Medical Management Versus TAG Device + Medical Management for Acute Uncomplicated Type B Dissection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Presence of acute uncomplicated type B aortic dissection~2. Able to tolerate endotracheal intubation and general anesthesia~3. Maximum transverse diameter of the descending thoracic aorta \< 55 mm and absence of descending thoracic aortic aneurysm, regardless of etiology.~4. Arterial anatomy is appropriate for stent graft therapy~Exclusion Criteria:~1. ASA classification = V~2. Severe renal insufficiency defined as SVS risk renal status = 3~3. Severe respiratory insufficiency defined as SVS risk pulmonary status = 3~4. Presence of connective tissue disease~5. Active infection or active vasculitides~6. Positive pregnancy test~7. Participation in another medical research study within 3 months of study enrollment~8. Myocardial infarction or cerebrovascular accident within 6 weeks prior to study enrollment~9. Planned concomitant surgical procedures (other than left subclavian artery transposition or bypass), or major surgery within 30 days of study enrollment~10. History of drug abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): TAG+BMT
- 2 (Type: ACTIVE_COMPARATOR): BMT alone

Based on this trial design, predict the completion outcome and termination type (if applicable).